Transepithelial resistance can be regulated by the intestinal brush-border Na(+)/H(+) exchanger NHE3

Am J Physiol Cell Physiol. 2000 Dec;279(6):C1918-24. doi: 10.1152/ajpcell.2000.279.6.C1918.

Abstract

Initiation of intestinal Na(+)-glucose cotransport results in transient cell swelling and sustained increases in tight junction permeability. Since Na(+)/H(+) exchange has been implicated in volume regulation after physiological cell swelling, we hypothesized that Na(+)/H(+) exchange might also be required for Na(+)-glucose cotransport-dependent tight junction regulation. In Caco-2 monolayers with active Na(+)-glucose cotransport, inhibition of Na(+)/H(+) exchange with 200 microM 5-(N,N-dimethyl)- amiloride induced 36 +/- 2% increases in transepithelial resistance (TER). Evaluation using multiple Na(+)/H(+) exchange inhibitors showed that inhibition of the Na(+)/H(+) exchanger 3 (NHE3) isoform was most closely related to TER increases. TER increases due to NHE3 inhibition were related to cytoplasmic acidification because cytoplasmic alkalinization with 5 mM NH(4)Cl prevented both cytoplasmic acidification and TER increases. However, NHE3 inhibition did not affect TER when Na(+)-glucose cotransport was inhibited. Myosin II regulatory light chain (MLC) phosphorylation decreased up to 43 +/- 5% after inhibition of Na(+)/H(+) exchange, similar to previous studies that associate decreased MLC phosphorylation with increased TER after inhibition of Na(+)-glucose cotransport. However, NHE3 inhibitors did not diminish Na(+)-glucose cotransport. These data demonstrate that inhibition of NHE3 results in decreased MLC phosphorylation and increased TER and suggest that NHE3 may participate in the signaling pathway of Na(+)-glucose cotransport-dependent tight junction regulation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acids / metabolism
  • Alkalies / metabolism
  • Amiloride / pharmacology
  • Animals
  • Anti-Ulcer Agents / pharmacology
  • Antihypertensive Agents / pharmacology
  • Biological Transport / drug effects
  • Biological Transport / physiology
  • Caco-2 Cells
  • Cimetidine / pharmacology
  • Clonidine / pharmacology
  • Cytoplasm / metabolism
  • Diuretics / pharmacology
  • Electric Impedance
  • Electrophysiology
  • Epithelial Cells / cytology
  • Epithelial Cells / metabolism
  • Glucose / metabolism
  • Guanidines / pharmacology
  • Humans
  • Hydrogen-Ion Concentration
  • Intestinal Mucosa / metabolism*
  • Methacrylates / pharmacology
  • Microvilli / metabolism
  • Myosin Light Chains / metabolism
  • Myosin-Light-Chain Kinase / antagonists & inhibitors
  • Myosin-Light-Chain Kinase / metabolism
  • Phosphorylation
  • Sodium / metabolism
  • Sodium-Hydrogen Exchanger 3
  • Sodium-Hydrogen Exchangers / metabolism*
  • Sulfones / pharmacology
  • Tight Junctions / metabolism*

Substances

  • 3-(2-(3-guanidino-2-methyl-3-oxo-propenyl)-5-methylphenyl)-N-isopropylidene-2-methyl-acrylamide dihydrochloride
  • Acids
  • Alkalies
  • Anti-Ulcer Agents
  • Antihypertensive Agents
  • Diuretics
  • Guanidines
  • Methacrylates
  • Myosin Light Chains
  • SLC9A3 protein, human
  • Sodium-Hydrogen Exchanger 3
  • Sodium-Hydrogen Exchangers
  • Sulfones
  • 3-methylsulfonyl-4-piperidinobenzoyl guanidine
  • Amiloride
  • Cimetidine
  • Sodium
  • Myosin-Light-Chain Kinase
  • Glucose
  • Clonidine